|Articles|September 1, 2008
- Pharmaceutical Executive-09-01-2008
- Volume 0
- Issue 0
Industry Audit + Company of the Year 2008
Author(s)Bill Trombetta
Pharm Exec's 7th annual review of the top companies. We slice and dice the numbers to see who's the best a what. (pdf)
Advertisement
Articles in this issue
over 17 years ago
The New Codeover 17 years ago
Publish or Perishover 17 years ago
How Do You Solve a Problem Like Manufacturing?over 17 years ago
Foreign Affairsover 17 years ago
Tapping the Fountover 17 years ago
The M&A Numbersover 17 years ago
The Salesforce Software Shiftover 17 years ago
Unleash the Dragon 2over 17 years ago
Place Your Betsover 17 years ago
The Orphan OpportunityNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Report: Richard Pazdur Out as Director of CDER
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
4
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
5
